mRNA vaccine producer BioNTech announces expansion plans

Vaccine makers are ramping up production. Yet, not enough of the product is made to keep everyone safe from COVID.

The US and the EU are thinking about waiving patent protection to allow others to produce generic versions of proven vaccines.